
The traditional trial-and-error approach to drug discovery is rapidly being eclipsed by a sophisticated digital architecture that leverages high-performance computing to solve biological mysteries in record time. As the pharmaceutical industry moves deeper into this era of computational biology, the convergence of data science and life sciences has created a paradigm shift that redefines how molecules are identified, tested, and










